-+ 0.00%
-+ 0.00%
-+ 0.00%

Actuate Therapeutics Reports Positive Phase II Results for Elraglusib in Metastatic Salivary Gland Cancer

Reuters·12/15/2025 13:45:14

Please log in to view news